黄云华

[摘要] 目的 研究分析雷贝拉唑、奥美拉唑治疗老年性反流性食管炎的临床疗效。方法 2014年2月—2016年2月期间,在该院接收的老年性反流性食管炎患者中,方便选取72例作为研究对象,采用随机数字表法将患者分为两组,观察组和对照组,均为36例,观察组患者应用雷贝拉唑、奥美拉唑进行治疗,对照组应用奥美拉唑进行治疗,对两组治疗效果进行比较分析。结果 观察组患者治疗后胃部pH值(1.79±0.11)优于对照组(1.38±0.12),差异有统计学意义(P<0.05);观察组治疗有效率97.22%比对照组80.56%高,差异有统计学意义(P<0.05);两组患者均无明显不良反应发生。结论 雷贝拉唑、奥美拉唑治疗老年性反流性食管炎的临床疗效较好,值得推广应用。
[关键词] 雷贝拉唑;奥美拉唑;老年;反流性食管炎
[中图分类号] R57 [文献标识码] A [文章编号] 1674-0742(2017)01(c)-0134-03
Analysis of Clinical Curative Effect of Rabeprazole and Ome in Treatment of Reflux Esophagitis in the Tlderly
HUANG Yun-hua
Zhouxiang Town Health Center, Xiaogan, Hubei Province, 432915 China
[Abstract] Objective To research and analyze the clinical curative effect of Rabeprazole and ome in treatment of Reflux esophagitis in the elderly. Methods 72 cases of senile patients with Reflux esophagitis treated in our hospital from February 2014 to February 2016 were convenient selected and divided into two groups with 36 cases in each, the observation group were treated with Rabeprazole and ome, while the control group were treated with ome, and the treatment effect of the two groups was compared and analyzed. Results The breadbasket pH value after treatment in the observation group was better than that in the control group, [(1.79±0.11) vs (1.38±0.12)], and the difference had statistical significance(P<0.05), and the treatment effective rate in the observation group was higher than that in the control group(97.22% vs 80.56%), and the difference had statistical significance(P<0.05), and there was no obvious adverse reactions. Conclusion The clinical curative effect of Rabeprazole and ome in treatment of Reflux esophagitis in the elderly is better, which is worth promotion and application.
[Key words] Rabeprazole; Ome; Senile; Reflux esophagitis
反流性食管炎是老年群体常见消化系统疾病,患者通常有胸骨后通、烧心、反酸等症状,严重影响患者生活质量[1]。现于2014年2月—2016年2月期间,在该院接收的老年性反流性食管炎患者中,方便选取72例进行研究,探讨雷贝拉唑、奥美拉唑治疗老年性反流性食管炎的临床疗效,取得了一定的成果,现报道如下。
1 资料与方法
1.1 一般资料
在该院接收的老年性反流性食管炎患者中,方便选取72例作为研究对象,排除患有食管和胃底静脉曲张、消化性溃疡、药物过敏等疾病或近期服用过其他质子泵制剂等药物的患者,将患者分为观察组和对照组,均为36例。在观察组中,男患者19例,女性17例,年龄62~83岁,平均年龄(71.59±6.27)岁,在对照组中,男患者21例,女性15例,年龄61~85岁,平均年龄(71.34±6.30)岁。两组患者的基础资料差异无统计学意义(P>0.05)。
1.2 方法
對照组应用奥美拉唑进行治疗,患者使用奥美拉唑肠溶胶囊(批号:160523)1次/d,20 mg,晨起吞服方式给药,1周为1个疗程,持续治疗8个疗程。……